Skip to search formSkip to main contentSkip to account menu

Gelucire 50-02

Known as: G 50-02 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Fatty acid glycerol estersOils

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Formulation and in vitro release evaluation of Telmisartan melt dispersion and tablets
SUMMARY Telmisartan (TEL) melt dispersions and tablets were formulated using alkalisers and low melting excipients. Tablets were… 
2010
2010
BINDER AND SUPERDISINTEGRANT INFLUENCE ON THE PROPERTIES OF ORALLY DISINTEGRATING HIGH DOSES ACETAMINOPHEN TABLETS
The purpose of our study was the formulation and preparation of orally disintegrating tablets (ODT) containing an analgesic… 
2006
2006
Gelucire® 44/14 and Labrasol® in enhancing oral absorption of poorly absorbable drugs
2004
2004
Influence of cryogenic grinding on properties of a self-emulsifying formulation
Recently, self-emulsifying drug delivery systems (SEDDS) have been developed as a method to deliver lipophilic drugs. Gelucire… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)